(Scripps Research Institute) Mitochondrial damage is increasingly recognized as a key factor underlying neurodegenerative diseases including Alzheimer’s, Parkinson’s, and ALS. A new screening platform has identified a set of drug-like compounds that may protect them.

Original source: https://www.eurekalert.org/pub_releases/2020-01/sri-neo010820.php